Psoriatic arthritis: open trials in Canada

11 open trials have a site in Canada. Registry data; only the trial team decides who can take part.

NCT06668181
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Trial Treatment · Phase 3 · UCB Biopharma SRL
Ja0005 50646, Calgary · Ja0005 50644, Montreal · Ja0005 50645, Saskatoon
Registry updated 2026-10-23
NCT02418442
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Research · Duke University
University of Calgary - Alberta Children's Hospital, Calgary · IWK Health Center, Halifax · The Hospital for Sick Children, Toronto · University of Manitoba - Children's Hospital of Manitoba, Winnipeg
Registry updated 2026-10-21
NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Trial Treatment · Phase 1 · National Cancer Institute (NCI)
University Health Network, Princess Margaret Hospital, Toronto
Registry updated 2026-10-05
NCT06382051
Modifying PEST for Psoriatic Arthritis Screening
Trial Treatment · Novartis Pharmaceuticals
Barrie · Calgary · Edmonton · Fredericton · Greater Sudbury · Hamilton · Kelowna · London · Markham · Montreal · Ottawa · Québec · Richmond Hill · Saskatoon · Ste-Foy · Stoney Creek · Surrey · Toronto · Verdun · Waterloo · Winnipeg
Registry updated 2026-09-28
NCT06888193
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Trial Treatment · Phase 1 · UCB Biopharma SRL
Up0122 202, Calgary · Up0122 201, Vancouver
Registry updated 2026-09-18
NCT06100744
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Trial Treatment · Phase 3 · AbbVie
Alberta Children's Hospital /ID# 257880, Calgary · Hospital for Sick Children /ID# 257879, Toronto · British Columbia Children and Women's Hospital and Health Centre /ID# 257884, Vancouver
Registry updated 2026-09-01
NCT06454188
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Trial Treatment · Phase 4 · CARE ARTHRITIS LTD.
The Ottawa Hospital Research Institute, Ottawa · Groupe de Recherche en Maladies Osseuses (G.R.M.O.) Inc., Québec
Registry updated 2026-04-03
NCT07298265
Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
Research · Charite University, Berlin, Germany
University Health Network - University of Toronto, Toronto
Registry updated 2025-12-23
NCT06865105
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Trial Treatment · Phase 2 · AbbVie
Dr. Latha Naik Medical Professional Corporation /ID# 272803, Saskatoon · Centre de Recherche Musculo-Squelettique /ID# 274397, Trois-Rivières
Registry updated 2025-12-18
NCT07022756
Personalized Outreach for Equitable Treatment in Rheumatology
Trial Treatment · University of British Columbia
Pender Community Health Centre, Vancouver
Registry updated 2025-07-04
NCT05954364
Sex and Gender-based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis
Research · Women's College Hospital
Women's College Hospital, Toronto
Registry updated 2023-07-24

All Psoriatic arthritis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error